摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-(2,3,4,6-tetra-O-acetyl-α-D-galactopyranosyl)acetaldehyde | 193156-88-6

中文名称
——
中文别名
——
英文名称
2-(2,3,4,6-tetra-O-acetyl-α-D-galactopyranosyl)acetaldehyde
英文别名
2-(2,3,4,6-tetra-O-acetyl-α-D-galactopyranosyl)ethanal;[(2R,3S,4R,5S,6R)-3,4,5-triacetyloxy-6-(2-oxoethyl)oxan-2-yl]methyl acetate
2-(2,3,4,6-tetra-O-acetyl-α-D-galactopyranosyl)acetaldehyde化学式
CAS
193156-88-6
化学式
C16H22O10
mdl
——
分子量
374.345
InChiKey
FFERSWWEXDRJFC-RBGFHDKUSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    0.1
  • 重原子数:
    26
  • 可旋转键数:
    11
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.69
  • 拓扑面积:
    132
  • 氢给体数:
    0
  • 氢受体数:
    10

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量
    • 1
    • 2

反应信息

  • 作为反应物:
    描述:
    2-(2,3,4,6-tetra-O-acetyl-α-D-galactopyranosyl)acetaldehyde 在 poly(ethylene glycol) supported L-proline 作用下, 以 甲醇 为溶剂, 以99%的产率得到2-(2,3,4,6-tetraacetyl-β-D-galactopyranosyl)acetaldehyde
    参考文献:
    名称:
    合成和亲和力评价的小双齿霍乱毒素配体库:面向不可水解的神经节苷脂模拟物。
    摘要:
    合成并测试了一个以半乳糖和唾液酸为药效学碳水化合物残基的GM1神经节苷脂的不可水解模拟物的小型文库。所有化合物都是使用高效反应(包括点击化学方案)和避免O-糖苷键的高效反应前体合成的。一些活性最高的分子还具有进一步衍生化的特征,可用于与多价糖苷配基结合。通过弱亲和色谱法评估了它们对霍乱毒素的亲和力,从而可以系统地评估和选择最佳候选物。与单个药效团糖残基的亲和力相比,亲和力可以提高一个或两个数量级。
    DOI:
    10.1002/chem.200902469
  • 作为产物:
    参考文献:
    名称:
    通过氯肟-硫醇偶联合成糖偶联物
    摘要:
    引入聚糖是改善治疗性生物分子药理学特性的一种有效化学方法。在此,我们报道了通过氯肟-硫醇偶联物高效合成糖缀合物的方法。衍生自吡喃糖或呋喃糖的反应性糖基氯肟很容易与多种含巯基的底物偶联,包括肽、糖和硫酚。该方法具有反应条件温和、动力学快速的特点。水性介质和克级合成的能力证明了该方法在糖类与生物活性分子的生物偶联中的潜力。
    DOI:
    10.1021/acs.joc.4c00356
点击查看最新优质反应信息

文献信息

  • Synthesis of new C-glycosyl aza-β3-amino acids building blocks
    作者:Manuel Andreini、Anne-Sophie Felten、Hoang-Trang Tran Thien、Claude Taillefumier、Nadia Pellegrini-Moïse、Yves Chapleur
    DOI:10.1016/j.tetlet.2012.03.072
    日期:2012.5
    building blocks have been prepared from C-glycosyl aldehydes of gluco and galacto configuration by reductive amination and subsequent N-alkylation. These moieties were elaborated to β-dipeptides by elongation at the C- or the N-terminus establishing their ability to be incorporated in original glycosylated foldamers.
    新C-糖基化Ñ β -保护的杂- β 3 -氨基酸构建块已经从制备Ç的α-糖基醛葡糖和半乳糖构型通过还原胺化和随后的N-烷基化。这些部分通过在C或N端延伸而被精制为β-二肽,从而确立了它们被掺入原始糖基化折叠子的能力。
  • First round of a focused library of cholera toxin inhibitors
    作者:Črtomir Podlipnik、Ingrid Velter、Barbara La Ferla、Gilles Marcou、Laura Belvisi、Francesco Nicotra、Anna Bernardi
    DOI:10.1016/j.carres.2007.06.006
    日期:2007.9
    C-Galactosides have been used as scaffolds to design a library of non-hydrolysable inhibitors of cholera toxin (CT). Test elements from the library were synthesized and found to inhibit CT binding to an asialofetuin-coated SPR chip with micromolar affinity. Preliminary results are reported.
    C-半乳糖苷已被用作支架来设计霍乱毒素(CT)的不可抑制剂库。合成了来自该文库的测试元件,发现其以微摩尔亲和力抑制CT结合去唾液铁蛋白包被的SPR芯片。报告了初步结果。
  • Stereoselective synthesis of neo-C-glycopeptide building blocks: Towards a flexible and control-oriented design as probes for carbohydrate-protein interactions
    作者:Prabhat Arya、Sylvain Dion、George K.H Shimizu
    DOI:10.1016/s0960-894x(97)00255-2
    日期:1997.6
    Neo-C-glycopeptides (1-4) have been synthesized as building blocks to obtain higher neo-C-glycopeptides as probes for studying carbohydrate-protein interactions. A convergent approach for the synthesis of 4 has been developed, in which two galactose units are attached to a glycine derivative in a stepwise procedure (reductive amination followed by amide coupling) and finally coupling to the protected dipeptide having a free amino group on the side chain. (C) 1997 Elsevier Science Ltd.
  • α-Galactose based neoglycopeptides. Inhibition of verotoxin binding to globotriosylceramide
    作者:Prabhat Arya、Kristina M.K. Kutterer、Huiping Qin、Johanne Roby、Michael L. Barnes、Shuqiong Lin、Clifford A. Lingwood、Markus G. Peter
    DOI:10.1016/s0968-0896(99)00226-6
    日期:1999.12
    Solution and solid phase strategies for the synthesis of a-galactose based neoglycopeptide derivatives 2-13 were developed. Neoglycopeptides generated were tested for the inhibition of verotoxin binding to globotriosylceramide (Gb3) using ELISA. Among all of the compounds tested, only the lipid derivatives of neoglycopeptides, 11, 12 and 13 were found to be inhibitors, IC50 = 2.0 mM (11b and 12c) and 0.2 mM (11c and 13c). All of the inhibitors (11b, 11c, 12c and 13c) have a similar branching of the two alpha-galactosyl units at the N-terminal glycine residue of a short peptide and a lipid moiety attached at the C-terminal site. Both of these factors seem to be crucial for the inhibition. It is interesting to note that the inhibitors have only a portion of the natural trisaccharide ligand. The secondary groups either may contribute in sub-site oriented interactions with the protein receptors or may mimic the internal sugar units of the cell-surface ligand, Gb3. (C) 1999 Elsevier Science Ltd. All rights reserved.
  • <i>C</i>-Linked Galactosyl Serine AFGP Analogues as Potent Recrystallization Inhibitors
    作者:Suhuai Liu、Robert N. Ben
    DOI:10.1021/ol050677x
    日期:2005.6.1
    A series of C-linked antifreeze glycoprotein analogues have been prepared to evaluate antifreeze activity as a function of distance between the carbohydrate moiety and polypeptide backbone. The building blocks for these analogues were prepared using either an olefin cross-metathesis or catalytic asymmetric hydrogenation. Analysis of antifreeze protein-specific activity revealed that only analogue 2a (n = 1) was a potent recrystallization inhibitor and thus has potential medical and industrial applications.
查看更多

同类化合物

(甲基3-(二甲基氨基)-2-苯基-2H-azirene-2-羧酸乙酯) (±)-盐酸氯吡格雷 (±)-丙酰肉碱氯化物 (d(CH2)51,Tyr(Me)2,Arg8)-血管加压素 (S)-(+)-α-氨基-4-羧基-2-甲基苯乙酸 (S)-阿拉考特盐酸盐 (S)-赖诺普利-d5钠 (S)-2-氨基-5-氧代己酸,氢溴酸盐 (S)-2-[[[(1R,2R)-2-[[[3,5-双(叔丁基)-2-羟基苯基]亚甲基]氨基]环己基]硫脲基]-N-苄基-N,3,3-三甲基丁酰胺 (S)-2-[3-[(1R,2R)-2-(二丙基氨基)环己基]硫脲基]-N-异丙基-3,3-二甲基丁酰胺 (S)-1-(4-氨基氧基乙酰胺基苄基)乙二胺四乙酸 (S)-1-[N-[3-苯基-1-[(苯基甲氧基)羰基]丙基]-L-丙氨酰基]-L-脯氨酸 (R)-乙基N-甲酰基-N-(1-苯乙基)甘氨酸 (R)-丙酰肉碱-d3氯化物 (R)-4-N-Cbz-哌嗪-2-甲酸甲酯 (R)-3-氨基-2-苄基丙酸盐酸盐 (R)-1-(3-溴-2-甲基-1-氧丙基)-L-脯氨酸 (N-[(苄氧基)羰基]丙氨酰-N〜5〜-(diaminomethylidene)鸟氨酸) (6-氯-2-吲哚基甲基)乙酰氨基丙二酸二乙酯 (4R)-N-亚硝基噻唑烷-4-羧酸 (3R)-1-噻-4-氮杂螺[4.4]壬烷-3-羧酸 (3-硝基-1H-1,2,4-三唑-1-基)乙酸乙酯 (2S,4R)-Boc-4-环己基-吡咯烷-2-羧酸 (2S,3S,5S)-2-氨基-3-羟基-1,6-二苯己烷-5-N-氨基甲酰基-L-缬氨酸 (2S,3S)-3-((S)-1-((1-(4-氟苯基)-1H-1,2,3-三唑-4-基)-甲基氨基)-1-氧-3-(噻唑-4-基)丙-2-基氨基甲酰基)-环氧乙烷-2-羧酸 (2S)-2,6-二氨基-N-[4-(5-氟-1,3-苯并噻唑-2-基)-2-甲基苯基]己酰胺二盐酸盐 (2S)-2-氨基-N,3,3-三甲基-N-(苯甲基)丁酰胺 (2S)-2-氨基-3-甲基-N-2-吡啶基丁酰胺 (2S)-2-氨基-3,3-二甲基-N-(苯基甲基)丁酰胺, (2S)-2-氨基-3,3-二甲基-N-2-吡啶基丁酰胺 (2S,4R)-1-((S)-2-氨基-3,3-二甲基丁酰基)-4-羟基-N-(4-(4-甲基噻唑-5-基)苄基)吡咯烷-2-甲酰胺盐酸盐 (2R,3'S)苯那普利叔丁基酯d5 (2R)-2-氨基-3,3-二甲基-N-(苯甲基)丁酰胺 (2-氯丙烯基)草酰氯 (1S,3S,5S)-2-Boc-2-氮杂双环[3.1.0]己烷-3-羧酸 (1R,5R,6R)-5-(1-乙基丙氧基)-7-氧杂双环[4.1.0]庚-3-烯-3-羧酸乙基酯 (1R,4R,5S,6R)-4-氨基-2-氧杂双环[3.1.0]己烷-4,6-二羧酸 齐特巴坦 齐德巴坦钠盐 齐墩果-12-烯-28-酸,2,3-二羟基-,苯基甲基酯,(2a,3a)- 齐墩果-12-烯-28-酸,2,3-二羟基-,羧基甲基酯,(2a,3b)-(9CI) 黄酮-8-乙酸二甲氨基乙基酯 黄荧菌素 黄体生成激素释放激素(1-6) 黄体生成激素释放激素 (1-5) 酰肼 黄体瑞林 麦醇溶蛋白 麦角硫因 麦芽聚糖六乙酸酯 麦根酸